Bulletin
Investor Alert

New York Markets After Hours

Sanofi

OTC: SNYNF

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Mar 20, 2023, 12:42 p.m.

/zigman2/quotes/205505035/composite

$

96.00

Change

+0.93 +0.98%

Volume

Volume 1,350

Quotes are delayed by 20 min

/zigman2/quotes/205505035/composite

Previous close

$ 95.07

$ 96.00

Change

+0.93 +0.98%

Day low

Day high

$96.00

$96.00

Open

52 week low

52 week high

$73.31

$112.50

Open

Insider Actions for Sanofi

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
12/22/2022 Emile Voest
500   Acquisition at $91.34 per share. 45,670
09/23/2022 Frédéric Oudéa
320   Acquisition at $78 per share. 24,960
09/06/2022 Carole Gabriella Ferrand
1   Acquisition at $80.62 per share. 80
12/22/2021 Barbara Lavernos
500   Acquisition at $87.7 per share. 43,850
12/22/2021 Barbara Lavernos
500   Acquisition at $87.7 per share. 43,850
11/18/2020 Rachel Duan
601   Acquisition at $85.63 per share. 51,463
11/18/2020 Rachel Duan
132   Acquisition at $85.62 per share. 11,301
11/18/2020 Rachel Duan
267   Acquisition at $85.5 per share. 22,828
11/12/2020 Lise Kingo
1,000   Acquisition at $85.2 per share. 85,204
02/21/2020 Sanofi
96,700   Acquisition at $93.07 per share. 8,999,665
02/20/2020 Sanofi
84,000   Acquisition at $93.78 per share. 7,877,830
02/19/2020 Sanofi
60,000   Acquisition at $94.29 per share. 5,657,406
02/18/2020 Sanofi
27,700   Acquisition at $92.45 per share. 2,560,809

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
0 Sales
500
0
Last 6 months
2 Purchases
0 Sales
820
0
Last 12 months
3 Purchases
0 Sales
821
0

Officers and Executives

Mr. Serge Weinberg
Chairman
Mr. Paul Hudson
Chief Executive Officer & Director
Mr. Jean-Baptiste Chasseloup de Chatillon
Chief Financial Officer & Executive Vice President
Dr. Dietmar P. Berger
Chief Medical Officer & Global Head-Development
Dr. Nestle Frank
Global Head-Immunology Therapeutic Research Area
Dr. Arnaud Robert
Chief Digital Officer & Executive Vice President
Ms. Julie van Ongevalle
Executive VP & Head-Consumer Healthcare
Mr. William J. Sibold
EVP-Specialty Care & President-North America
Ms. Alexandra Roger
Head-Securities Law & Capital Markets
Mr. Brendan OCallaghan
Executive Vice President & Head-Industrial Affairs
Mr. Josep Catlla
Head-Communication
Mr. Raj Verma
Chief Diversity, Culture & Experience Officer
Ms. Noel M. Geoffroy
Head-North America Consumer Healthcare
Mr. Olivier Antoine M. Charmeil
Executive Vice President-General Medicines
Mr. Yann Tran
Director
Dr. Wolfgang Laux
Director
Mr. Frédéric Oudéa
Director
Mr. Christophe Babule
Director
Ms. Eva Schäfer-Jansen
Investor Relations Contact
Ms. Natalie Bickford
Chief People Officer & Executive Vice President
Ms. Claire Terrazas
Vice President-Corporate Legal Affairs
Mr. Roy Papatheodorou
General Counsel
Mr. Arnaud Delépine
Investor Relations Officer
Ms. Rachel Duan
Independent Non-Executive Director
Ms. Lise Kingo
Independent Director
Mr. Gilles Schnepp
Independent Director
Ms. Barbara Lavernos
Independent Director
Ms. Carole Gabriella Ferrand
Independent Director
Dr. Emile Voest
Independent Director
Dr. Antoine Yver
Independent Director
Ms. Fabienne Lecorvaisier
Independent Director
Mr. Patrick Kron
Independent Director
Ms. Diane D. Souza
Independent Director
Dr. Thomas C. Südhof
Independent Director
Link to MarketWatch's Slice.